Because several reports have suggested that co-treatment with DNA repair inhibitors enhances the efficacy of anticancer drugs, we examined whether ouabain, as a FA/BRCA pathway inhibitor, could potentiate cytotoxicity of MMC against tumor cells. The gene discussed is FANCA; the disease is neoplasm.